Global Pet Biopharmaceuticals Market Insights, Forecast to 2028
SKU ID : QYR-20529204 | Publishing Date : 18-Mar-2022 | No. of pages : 114
Detailed TOC of Global Pet Biopharmaceuticals Market Insights, Forecast to 2028
1 Report Business Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Biopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antiparasitic
1.2.3 Biological Products
1.2.4 Antibacterial
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pet Biopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prevention
1.3.3 Treatment
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pet Biopharmaceuticals Market Perspective (2017-2028)
2.2 Pet Biopharmaceuticals Growth Trends by Region
2.2.1 Pet Biopharmaceuticals Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pet Biopharmaceuticals Historic Market Size by Region (2017-2022)
2.2.3 Pet Biopharmaceuticals Forecasted Market Size by Region (2023-2028)
2.3 Pet Biopharmaceuticals Market Dynamics
2.3.1 Pet Biopharmaceuticals Industry Trends
2.3.2 Pet Biopharmaceuticals Market Drivers
2.3.3 Pet Biopharmaceuticals Market Challenges
2.3.4 Pet Biopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Biopharmaceuticals Players by Revenue
3.1.1 Global Top Pet Biopharmaceuticals Players by Revenue (2017-2022)
3.1.2 Global Pet Biopharmaceuticals Revenue Market Share by Players (2017-2022)
3.2 Global Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pet Biopharmaceuticals Revenue
3.4 Global Pet Biopharmaceuticals Market Concentration Ratio
3.4.1 Global Pet Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Biopharmaceuticals Revenue in 2021
3.5 Pet Biopharmaceuticals Key Players Head office and Area Served
3.6 Key Players Pet Biopharmaceuticals Product Solution and Service
3.7 Date of Enter into Pet Biopharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Biopharmaceuticals Breakdown Data by Type
4.1 Global Pet Biopharmaceuticals Historic Market Size by Type (2017-2022)
4.2 Global Pet Biopharmaceuticals Forecasted Market Size by Type (2023-2028)
5 Pet Biopharmaceuticals Breakdown Data by Application
5.1 Global Pet Biopharmaceuticals Historic Market Size by Application (2017-2022)
5.2 Global Pet Biopharmaceuticals Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pet Biopharmaceuticals Market Size (2017-2028)
6.2 North America Pet Biopharmaceuticals Market Size by Type
6.2.1 North America Pet Biopharmaceuticals Market Size by Type (2017-2022)
6.2.2 North America Pet Biopharmaceuticals Market Size by Type (2023-2028)
6.2.3 North America Pet Biopharmaceuticals Market Share by Type (2017-2028)
6.3 North America Pet Biopharmaceuticals Market Size by Application
6.3.1 North America Pet Biopharmaceuticals Market Size by Application (2017-2022)
6.3.2 North America Pet Biopharmaceuticals Market Size by Application (2023-2028)
6.3.3 North America Pet Biopharmaceuticals Market Share by Application (2017-2028)
6.4 North America Pet Biopharmaceuticals Market Size by Country
6.4.1 North America Pet Biopharmaceuticals Market Size by Country (2017-2022)
6.4.2 North America Pet Biopharmaceuticals Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pet Biopharmaceuticals Market Size (2017-2028)
7.2 Europe Pet Biopharmaceuticals Market Size by Type
7.2.1 Europe Pet Biopharmaceuticals Market Size by Type (2017-2022)
7.2.2 Europe Pet Biopharmaceuticals Market Size by Type (2023-2028)
7.2.3 Europe Pet Biopharmaceuticals Market Share by Type (2017-2028)
7.3 Europe Pet Biopharmaceuticals Market Size by Application
7.3.1 Europe Pet Biopharmaceuticals Market Size by Application (2017-2022)
7.3.2 Europe Pet Biopharmaceuticals Market Size by Application (2023-2028)
7.3.3 Europe Pet Biopharmaceuticals Market Share by Application (2017-2028)
7.4 Europe Pet Biopharmaceuticals Market Size by Country
7.4.1 Europe Pet Biopharmaceuticals Market Size by Country (2017-2022)
7.4.2 Europe Pet Biopharmaceuticals Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Biopharmaceuticals Market Size (2017-2028)
8.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Type
8.2.1 Asia-Pacific Pet Biopharmaceuticals Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pet Biopharmaceuticals Market Share by Type (2017-2028)
8.3 Asia-Pacific Pet Biopharmaceuticals Market Size by Application
8.3.1 Asia-Pacific Pet Biopharmaceuticals Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pet Biopharmaceuticals Market Share by Application (2017-2028)
8.4 Asia-Pacific Pet Biopharmaceuticals Market Size by Region
8.4.1 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pet Biopharmaceuticals Market Size (2017-2028)
9.2 Latin America Pet Biopharmaceuticals Market Size by Type
9.2.1 Latin America Pet Biopharmaceuticals Market Size by Type (2017-2022)
9.2.2 Latin America Pet Biopharmaceuticals Market Size by Type (2023-2028)
9.2.3 Latin America Pet Biopharmaceuticals Market Share by Type (2017-2028)
9.3 Latin America Pet Biopharmaceuticals Market Size by Application
9.3.1 Latin America Pet Biopharmaceuticals Market Size by Application (2017-2022)
9.3.2 Latin America Pet Biopharmaceuticals Market Size by Application (2023-2028)
9.3.3 Latin America Pet Biopharmaceuticals Market Share by Application (2017-2028)
9.4 Latin America Pet Biopharmaceuticals Market Size by Country
9.4.1 Latin America Pet Biopharmaceuticals Market Size by Country (2017-2022)
9.4.2 Latin America Pet Biopharmaceuticals Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Biopharmaceuticals Market Size (2017-2028)
10.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Type
10.2.1 Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pet Biopharmaceuticals Market Share by Type (2017-2028)
10.3 Middle East & Africa Pet Biopharmaceuticals Market Size by Application
10.3.1 Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pet Biopharmaceuticals Market Share by Application (2017-2028)
10.4 Middle East & Africa Pet Biopharmaceuticals Market Size by Country
10.4.1 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Pet Biopharmaceuticals Introduction
11.1.4 Zoetis Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.1.5 Zoetis Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Introduction
11.2.4 Boehringer Ingelheim Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Pet Biopharmaceuticals Introduction
11.3.4 Merck Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.3.5 Merck Recent Developments
11.4 Elanco
11.4.1 Elanco Company Details
11.4.2 Elanco Business Overview
11.4.3 Elanco Pet Biopharmaceuticals Introduction
11.4.4 Elanco Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.4.5 Elanco Recent Developments
11.5 Virbac
11.5.1 Virbac Company Details
11.5.2 Virbac Business Overview
11.5.3 Virbac Pet Biopharmaceuticals Introduction
11.5.4 Virbac Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.5.5 Virbac Recent Developments
11.6 Dechra Veterinary Products
11.6.1 Dechra Veterinary Products Company Details
11.6.2 Dechra Veterinary Products Business Overview
11.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Introduction
11.6.4 Dechra Veterinary Products Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.6.5 Dechra Veterinary Products Recent Developments
11.7 Ceva
11.7.1 Ceva Company Details
11.7.2 Ceva Business Overview
11.7.3 Ceva Pet Biopharmaceuticals Introduction
11.7.4 Ceva Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.7.5 Ceva Recent Developments
11.8 Vetoquinol
11.8.1 Vetoquinol Company Details
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Pet Biopharmaceuticals Introduction
11.8.4 Vetoquinol Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.8.5 Vetoquinol Recent Developments
11.9 Ouro Fino Saude
11.9.1 Ouro Fino Saude Company Details
11.9.2 Ouro Fino Saude Business Overview
11.9.3 Ouro Fino Saude Pet Biopharmaceuticals Introduction
11.9.4 Ouro Fino Saude Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.9.5 Ouro Fino Saude Recent Developments
11.10 Norbrook
11.10.1 Norbrook Company Details
11.10.2 Norbrook Business Overview
11.10.3 Norbrook Pet Biopharmaceuticals Introduction
11.10.4 Norbrook Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.10.5 Norbrook Recent Developments
11.11 Jindun
11.11.1 Jindun Company Details
11.11.2 Jindun Business Overview
11.11.3 Jindun Pet Biopharmaceuticals Introduction
11.11.4 Jindun Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.11.5 Jindun Recent Developments
11.12 Chopperlvya Animal Health
11.12.1 Chopperlvya Animal Health Company Details
11.12.2 Chopperlvya Animal Health Business Overview
11.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Introduction
11.12.4 Chopperlvya Animal Health Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.12.5 Chopperlvya Animal Health Recent Developments
11.13 CAHIC
11.13.1 CAHIC Company Details
11.13.2 CAHIC Business Overview
11.13.3 CAHIC Pet Biopharmaceuticals Introduction
11.13.4 CAHIC Revenue in Pet Biopharmaceuticals Business (2017-2022)
11.13.5 CAHIC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Figures, Tables and Charts Available in Global Pet Biopharmaceuticals Market Insights, Forecast to 2028
List of TablesTable 1. Global Pet Biopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Antiparasitic
Table 3. Key Players of Biological Products
Table 4. Key Players of Antibacterial
Table 5. Key Players of Others
Table 6. Global Pet Biopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Pet Biopharmaceuticals Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Pet Biopharmaceuticals Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Pet Biopharmaceuticals Market Share by Region (2017-2022)
Table 10. Global Pet Biopharmaceuticals Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Pet Biopharmaceuticals Market Share by Region (2023-2028)
Table 12. Pet Biopharmaceuticals Market Trends
Table 13. Pet Biopharmaceuticals Market Drivers
Table 14. Pet Biopharmaceuticals Market Challenges
Table 15. Pet Biopharmaceuticals Market Restraints
Table 16. Global Pet Biopharmaceuticals Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Pet Biopharmaceuticals Revenue Share by Players (2017-2022)
Table 18. Global Top Pet Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2021)
Table 19. Ranking of Global Top Pet Biopharmaceuticals Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Pet Biopharmaceuticals Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pet Biopharmaceuticals Product Solution and Service
Table 23. Date of Enter into Pet Biopharmaceuticals Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Pet Biopharmaceuticals Revenue Market Share by Type (2017-2022)
Table 27. Global Pet Biopharmaceuticals Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Pet Biopharmaceuticals Revenue Market Share by Type (2023-2028)
Table 29. Global Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Pet Biopharmaceuticals Revenue Share by Application (2017-2022)
Table 31. Global Pet Biopharmaceuticals Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Pet Biopharmaceuticals Revenue Share by Application (2023-2028)
Table 33. North America Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Pet Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Pet Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Pet Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Pet Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Pet Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Pet Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Pet Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Pet Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Pet Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Pet Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Pet Biopharmaceuticals Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Pet Biopharmaceuticals Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Pet Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Pet Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Pet Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Pet Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Pet Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Pet Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Pet Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Pet Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
Table 63. Zoetis Company Details
Table 64. Zoetis Business Overview
Table 65. Zoetis Pet Biopharmaceuticals Product
Table 66. Zoetis Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 67. Zoetis Recent Developments
Table 68. Boehringer Ingelheim Company Details
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Pet Biopharmaceuticals Product
Table 71. Boehringer Ingelheim Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Developments
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Pet Biopharmaceuticals Product
Table 76. Merck Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 77. Merck Recent Developments
Table 78. Elanco Company Details
Table 79. Elanco Business Overview
Table 80. Elanco Pet Biopharmaceuticals Product
Table 81. Elanco Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 82. Elanco Recent Developments
Table 83. Virbac Company Details
Table 84. Virbac Business Overview
Table 85. Virbac Pet Biopharmaceuticals Product
Table 86. Virbac Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 87. Virbac Recent Developments
Table 88. Dechra Veterinary Products Company Details
Table 89. Dechra Veterinary Products Business Overview
Table 90. Dechra Veterinary Products Pet Biopharmaceuticals Product
Table 91. Dechra Veterinary Products Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 92. Dechra Veterinary Products Recent Developments
Table 93. Ceva Company Details
Table 94. Ceva Business Overview
Table 95. Ceva Pet Biopharmaceuticals Product
Table 96. Ceva Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 97. Ceva Recent Developments
Table 98. Vetoquinol Company Details
Table 99. Vetoquinol Business Overview
Table 100. Vetoquinol Pet Biopharmaceuticals Product
Table 101. Vetoquinol Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 102. Vetoquinol Recent Developments
Table 103. Ouro Fino Saude Company Details
Table 104. Ouro Fino Saude Business Overview
Table 105. Ouro Fino Saude Pet Biopharmaceuticals Product
Table 106. Ouro Fino Saude Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 107. Ouro Fino Saude Recent Developments
Table 108. Norbrook Company Details
Table 109. Norbrook Business Overview
Table 110. Norbrook Pet Biopharmaceuticals Product
Table 111. Norbrook Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 112. Norbrook Recent Developments
Table 113. Jindun Company Details
Table 114. Jindun Business Overview
Table 115. Jindun Pet Biopharmaceuticals Product
Table 116. Jindun Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 117. Jindun Recent Developments
Table 118. Chopperlvya Animal Health Company Details
Table 119. Chopperlvya Animal Health Business Overview
Table 120. Chopperlvya Animal Health Pet Biopharmaceuticals Product
Table 121. Chopperlvya Animal Health Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 122. Chopperlvya Animal Health Recent Developments
Table 123. CAHIC Company Details
Table 124. CAHIC Business Overview
Table 125. CAHIC Pet Biopharmaceuticals Product
Table 126. CAHIC Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million)
Table 127. CAHIC Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Biopharmaceuticals Market Share by Type: 2021 VS 2028
Figure 2. Antiparasitic Features
Figure 3. Biological Products Features
Figure 4. Antibacterial Features
Figure 5. Others Features
Figure 6. Global Pet Biopharmaceuticals Market Share by Application: 2021 VS 2028
Figure 7. Prevention Case Studies
Figure 8. Treatment Case Studies
Figure 9. Pet Biopharmaceuticals Report Years Considered
Figure 10. Global Pet Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Pet Biopharmaceuticals Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Pet Biopharmaceuticals Market Share by Region: 2021 VS 2028
Figure 13. Global Pet Biopharmaceuticals Market Share by Players in 2021
Figure 14. Global Top Pet Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Pet Biopharmaceuticals Revenue in 2021
Figure 16. North America Pet Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Pet Biopharmaceuticals Market Size Market Share by Type (2017-2028)
Figure 18. North America Pet Biopharmaceuticals Market Size Market Share by Application (2017-2028)
Figure 19. North America Pet Biopharmaceuticals Market Size Share by Country (2017-2028)
Figure 20. United States Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Pet Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Pet Biopharmaceuticals Market Size Market Share by Type (2017-2028)
Figure 24. Europe Pet Biopharmaceuticals Market Size Market Share by Application (2017-2028)
Figure 25. Europe Pet Biopharmaceuticals Market Size Share by Country (2017-2028)
Figure 26. Germany Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Pet Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Pet Biopharmaceuticals Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Pet Biopharmaceuticals Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Pet Biopharmaceuticals Market Size Share by Region (2017-2028)
Figure 36. China Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Pet Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Pet Biopharmaceuticals Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Pet Biopharmaceuticals Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Pet Biopharmaceuticals Market Size Share by Country (2017-2028)
Figure 46. Mexico Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Pet Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Pet Biopharmaceuticals Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Pet Biopharmaceuticals Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Pet Biopharmaceuticals Market Size Share by Country (2017-2028)
Figure 52. Turkey Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Zoetis Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 56. Boehringer Ingelheim Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 57. Merck Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 58. Elanco Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 59. Virbac Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 60. Dechra Veterinary Products Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 61. Ceva Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 62. Vetoquinol Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 63. Ouro Fino Saude Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 64. Norbrook Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 65. Jindun Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 66. Chopperlvya Animal Health Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 67. CAHIC Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Keyplayers in Global Pet Biopharmaceuticals Market Insights, Forecast to 2028
ZoetisBoehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC